Assessing the Efficacy and Safety of Dapagliflozin and Empagliflozin as an Add-on Therapy for Lowering Glycated Hemoglobin and Weight in Type 2 Diabetes Mellitus Patients
Introduction: Sodium glucose co-transporter-2 inhibitors (SGLT2-1) are a novel class of antidiabetic drugs, with an insulin-independent mechanism of action. Dapagliflozin and Empagliflozin are commonly used SGLT2-1 in diabetes mellitus. The study was planned to assess the efficacy and safety of SGLT...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sonali Sharma on behalf of Rajasthan University of Health Sciences
2025-06-01
|
| Series: | RUHS Journal of Health Sciences |
| Subjects: | |
| Online Access: | https://ruhsjhs.in/articleDetails.php?artid=TXpNMQ== |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|